More than 10,000 MP government doctors are on continuous strike after failing to hold talks with the government

Published Date: 17 Feb 2023

Bhopal: Over 10,000...

Read Full News

Latest News



Todays Updates


Building the Next Era of ALS Clinical Research and Trials Marco Meglio


Ryan Donaghy, MD, an assistant professor of neurology at Northwestern Medicine, discussed the evolving landscape of ALS clinical trials, including advances in biomarkers, genetics, and modern trial design.

Treating Obstructive Sleep Apnea: Beyond CPAP and Toward Hypoglossal Nerve Stimulation Vaishal Shah, MD, MPH, FAASM, FAAP


Vaishal Shah, MD, MPH, FAASM, FAAP, center director of the Sleep Disorders Center at Cleveland Clinic, spoke on the changes in how obstructive sleep apnea is treated, moving away from CPAP to more novel approaches.

Expert Panel Publishes Revised Consensus Recommendations for Diagnosis and Management of NMOSD Isabella Ciccone, MPH


In a newly published study, researchers developed expert-driven, evidence-based, up-to-date consensus recommendations for managing neuromyelitis optica spectrum disorder in Saudi Arabia.

Understanding Atacicept & 36-Week ORIGIN 3 Data from Kidney Week 2025, With Jonathan Barratt, MBChB, PhD Jonathan Barratt, MBChB, PhD, FRCP


Jonathan Barratt, MBChB, PhD, discusses 36-week atacicept data from ASN Kidney Week 2025.

Exploring the New COPD Era: Biologics, Guidelines, and Real-World Barriers


Exploring the New COPD Era: Biologics, Guidelines, and Real-World Barriers

Telitacicept Achieves Primary Endpoint in IgA Nephropathy Phase 3 Study


Telitacicept Achieves Primary Endpoint in IgA Nephropathy Phase 3 Study

Pre-Conception Hypertension Linked to Adverse Pregnancy Outcomes in IgA Nephropathy


Pre-Conception Hypertension Linked to Adverse Pregnancy Outcomes in IgA Nephropathy

Todays Updates


Building the Next Era of ALS Clinical Research and Trials Marco Meglio


Ryan Donaghy, MD, an assistant professor of neurology at Northwestern Medicine, discussed the evolving landscape of ALS clinical trials, including advances in biomarkers, genetics, and modern trial design.

Treating Obstructive Sleep Apnea: Beyond CPAP and Toward Hypoglossal Nerve Stimulation Vaishal Shah, MD, MPH, FAASM, FAAP


Vaishal Shah, MD, MPH, FAASM, FAAP, center director of the Sleep Disorders Center at Cleveland Clinic, spoke on the changes in how obstructive sleep apnea is treated, moving away from CPAP to more novel approaches.

Expert Panel Publishes Revised Consensus Recommendations for Diagnosis and Management of NMOSD Isabella Ciccone, MPH


In a newly published study, researchers developed expert-driven, evidence-based, up-to-date consensus recommendations for managing neuromyelitis optica spectrum disorder in Saudi Arabia.

Understanding Atacicept & 36-Week ORIGIN 3 Data from Kidney Week 2025, With Jonathan Barratt, MBChB, PhD Jonathan Barratt, MBChB, PhD, FRCP


Jonathan Barratt, MBChB, PhD, discusses 36-week atacicept data from ASN Kidney Week 2025.

Exploring the New COPD Era: Biologics, Guidelines, and Real-World Barriers


Exploring the New COPD Era: Biologics, Guidelines, and Real-World Barriers

Telitacicept Achieves Primary Endpoint in IgA Nephropathy Phase 3 Study


Telitacicept Achieves Primary Endpoint in IgA Nephropathy Phase 3 Study

Pre-Conception Hypertension Linked to Adverse Pregnancy Outcomes in IgA Nephropathy


Pre-Conception Hypertension Linked to Adverse Pregnancy Outcomes in IgA Nephropathy

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Scientists call into question safety of potential new anticancer treatment

2.

Hybrid imaging test combines antibody and radioisotope for early lung cancer detection

3.

Sickle Cell Disease Drug Pulled From Global Markets

4.

For MDS-Related Anemia, Telomerase Inhibitor Approved.

5.

A researcher has found that yoga exhibits the "most improvement" in helping long-term cancer survivors restore their brain health.


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot